Literature DB >> 12630961

Ileal adenocarcinoma in a mild phenotype of abetalipoproteinemia.

K Al-Shali1, J Wang, F Rosen, R A Hegele.   

Abstract

Abetalipoproteinemia (ABL) is a rare autosomal recessive disorder that is characterized by defective assembly and secretion of plasma apolipoprotein (apo) B-containing lipoproteins. This disorder results from mutations in the MTP gene encoding the microsomal triglyceride transfer protein. We report a 58-year-old male homozygote for a missense mutation, S590I, in MTP. The patient had a lifelong history of fat malabsorption, but was only diagnosed with ABL at age 52, based upon such classic features as absence of apo B-containing lipoproteins, acanthocytosis, atypical retinitis pigmentosa and markedly depressed serum beta-carotene concentration. However, his presentation was notable not only by survival to the sixth decade of life without specific treatment, but also by the absence of neurological involvement and by normal serum vitamin E concentration. He subsequently developed adenocarcinoma of the ileum, which required ileal resection. Therefore, this missense mutation appears to be associated with a late-presenting and relatively mild ABL phenotype that lacks some classical features, particularly neuropathy, but appears to be associated with other atypical features, specifically small intestinal cancer.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12630961     DOI: 10.1046/j.0009-9163.2002.00175.x

Source DB:  PubMed          Journal:  Clin Genet        ISSN: 0009-9163            Impact factor:   4.438


  11 in total

1.  An atypical case of abetalipoproteinaemia with severe fatty liver in the absence of steatorrhoea or acanthocytosis.

Authors:  Osamu Sakamoto; Daiki Abukawa; Junji Takeyama; Nobuhiro Arai; Makoto Nagano; Hiroaki Hattori; Tohru Egashira; Naohiko Sakai; Shizuya Yamashita; Kazuie Iinuma; Toshihiro Ohura
Journal:  Eur J Pediatr       Date:  2005-09-06       Impact factor: 3.183

Review 2.  Aggressive statin therapy and the risk of malignancy.

Authors:  Joshua Liao; John A Farmer
Journal:  Curr Atheroscler Rep       Date:  2013-04       Impact factor: 5.113

3.  Primary deficiency of microsomal triglyceride transfer protein in human abetalipoproteinemia is associated with loss of CD1 function.

Authors:  Sebastian Zeissig; Stephanie K Dougan; Duarte C Barral; Yvonne Junker; Zhangguo Chen; Arthur Kaser; Madelyn Ho; Hannah Mandel; Adam McIntyre; Susan M Kennedy; Gavin F Painter; Natacha Veerapen; Gurdyal S Besra; Vincenzo Cerundolo; Simon Yue; Sarah Beladi; Samuel M Behar; Xiuxu Chen; Jenny E Gumperz; Karine Breckpot; Anna Raper; Amanda Baer; Mark A Exley; Robert A Hegele; Marina Cuchel; Daniel J Rader; Nicholas O Davidson; Richard S Blumberg
Journal:  J Clin Invest       Date:  2010-07-01       Impact factor: 14.808

4.  Molecular and functional analysis of two new MTTP gene mutations in an atypical case of abetalipoproteinemia.

Authors:  Mathilde Di Filippo; Hervé Créhalet; Marie Elisabeth Samson-Bouma; Véronique Bonnet; Lawrence P Aggerbeck; Jean-Pierre Rabès; Frederic Gottrand; Gérald Luc; Dominique Bozon; Agnès Sassolas
Journal:  J Lipid Res       Date:  2012-01-11       Impact factor: 5.922

5.  Lack of MTTP Activity in Pluripotent Stem Cell-Derived Hepatocytes and Cardiomyocytes Abolishes apoB Secretion and Increases Cell Stress.

Authors:  Ying Liu; Donna M Conlon; Xin Bi; Katherine J Slovik; Jianting Shi; Hailey I Edelstein; John S Millar; Ali Javaheri; Marina Cuchel; Evanthia E Pashos; Jahangir Iqbal; M Mahmood Hussain; Robert A Hegele; Wenli Yang; Stephen A Duncan; Daniel J Rader; Edward E Morrisey
Journal:  Cell Rep       Date:  2017-05-16       Impact factor: 9.423

6.  Loss of both phospholipid and triglyceride transfer activities of microsomal triglyceride transfer protein in abetalipoproteinemia.

Authors:  Irani Khatun; Meghan T Walsh; M Mahmood Hussain
Journal:  J Lipid Res       Date:  2013-03-08       Impact factor: 5.922

7.  Identification of two novel mutations and long-term follow-up in abetalipoproteinemia: a report of four cases.

Authors:  Laurence Chardon; Agnès Sassolas; Bernard Dingeon; Laurence Michel-Calemard; Michel Bovier-Lapierre; Philippe Moulin; Alain Lachaux
Journal:  Eur J Pediatr       Date:  2008-12-09       Impact factor: 3.183

8.  Intestine-Specific Mttp Deletion Increases the Severity of Experimental Colitis and Leads to Greater Tumor Burden in a Model of Colitis Associated Cancer.

Authors:  Yan Xie; Hitoshi Matsumoto; Ilke Nalbantoglu; Thomas A Kerr; Jianyang Luo; Deborah C Rubin; Susan Kennedy; Nicholas O Davidson
Journal:  PLoS One       Date:  2013-06-21       Impact factor: 3.240

9.  Molecular characterization of Tunisian families with abetalipoproteinemia and identification of a novel mutation in MTTP gene.

Authors:  Mohamed Najah; Sarraj Mohamed Youssef; Hrira Mohamed Yahia; Slimani Afef; Jelassi Awatef; Hammami Saber; Najjar Mohamed Fadhel; Agnès Sassolas; Slimane Mohamed Naceur
Journal:  Diagn Pathol       Date:  2013-04-04       Impact factor: 2.644

Review 10.  Abetalipoproteinemia: two case reports and literature review.

Authors:  Rola Zamel; Razi Khan; Rebecca L Pollex; Robert A Hegele
Journal:  Orphanet J Rare Dis       Date:  2008-07-08       Impact factor: 4.123

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.